Positively-charged, chalcone-hydroxypyrone hybrid ruthenium(II)-arene complexes functionalized with ethacrynic acid: Synthesis, characterizaion, and antitumor effect
- 22 November 2024
- journal article
- research article
- Published by Elsevier in Journal of Inorganic Biochemistry
- Vol. 263, 112778
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Monodentately-coordinated bioactive moieties in multimodal half-sandwich organoruthenium anticancer agentsCoordination Chemistry Reviews, 2021
- Recent Considerations in the Application of RAPTA‐C for Cancer Treatment and Perspectives for Its Combination with ImmunotherapiesAdvanced Therapeutics, 2019
- Cationic Ru(η6‐p‐cymene) Complexes of 3‐Hydroxy‐4‐pyr(id)ones – Lipophilic Triphenylphosphine as Co‐Ligand Is Key to Highly Stable and Cytotoxic Anticancer AgentsEuropean Journal of Inorganic Chemistry, 2016
- The development of RAPTA compounds for the treatment of tumorsCoordination Chemistry Reviews, 2016
- A bifunctional organometallic ruthenium drug with multiple modes of inducing apoptosisJBIC Journal of Biological Inorganic Chemistry, 2011
- Maltol‐Derived Ruthenium–Cymene Complexes with Tumor Inhibiting Properties: The Impact of Ligand–Metal Bond Stability on Anticancer Activity In VitroChemistry – A European Journal, 2009
- Rational Design of an Organometallic Glutathione Transferase InhibitorAngewandte Chemie International Edition, 2009
- Discovery of 3-acetyl-4-hydroxy-2-pyranone derivatives and their difluoridoborate complexes as a novel class of HIV-1 integrase InhibitorsBioorganic & Medicinal Chemistry, 2008
- Organometallic Ruthenium Inhibitors of Glutathione‐S‐Transferase P1‐1 as Anticancer DrugsChemMedChem, 2007
- Anti-tumour activity in non-small cell lung cancer models and toxicity profiles for novel ruthenium(II) based organo-metallic compoundsBiochemical Pharmacology, 2006